Annual Debt To Equity
-12.24
-41.76-141.46%
December 31, 2022
Summary
- As of February 10, 2025, BVXV annual debt to equity ratio is -12.24, with the most recent change of -41.76 (-141.46%) on December 31, 2022.
- During the last 3 years, BVXV annual debt to equity has fallen by -10.22 (-505.94%).
Performance
BVXV Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Debt To Equity
-3.46
+1.38+28.51%
June 30, 2023
Summary
- As of February 10, 2025, BVXV quarterly debt to equity ratio is -3.46, with the most recent change of +1.38 (+28.51%) on June 30, 2023.
- Over the past year, BVXV quarterly debt to equity has dropped by -20.71 (-120.06%).
Performance
BVXV Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
BVXV Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -141.5% | -120.1% |
3 y3 years | -505.9% | -65.5% |
5 y5 years | -100.0% | -379.0% |
BVXV Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -141.5% | at low | -111.7% | +253.8% |
5 y | 5-year | -141.5% | at low | -111.7% | +938.7% |
alltime | all time | -141.5% | at low | -111.7% | +938.7% |
BiondVax Pharmaceuticals Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | -3.46(-28.5%) |
Mar 2023 | - | -4.84(-60.5%) |
Dec 2022 | -12.24(-141.5%) | -12.24(-284.6%) |
Sep 2022 | - | 6.63(-61.6%) |
Jun 2022 | - | 17.25(+289.4%) |
Mar 2022 | - | 4.43(-85.0%) |
Dec 2021 | 29.52(-741.7%) | 29.52(+73.6%) |
Sep 2021 | - | 17.00(+172.4%) |
Jun 2021 | - | 6.24(+88.0%) |
Mar 2021 | - | 3.32(-172.2%) |
Dec 2020 | -4.60(+127.7%) | -4.60(-87.2%) |
Sep 2020 | - | -35.94(+1619.6%) |
Jun 2020 | - | -2.09(+1641.7%) |
Mar 2020 | - | -0.12(-94.1%) |
Dec 2019 | -2.02(-33.1%) | -2.02(-64.4%) |
Sep 2019 | - | -5.67(+245.7%) |
Jun 2019 | - | -1.64(-48.1%) |
Mar 2019 | - | -3.16(+4.6%) |
Dec 2018 | -3.02 | -3.02(-202.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | 2.95(+137.9%) |
Jun 2018 | - | 1.24(>+9900.0%) |
Mar 2018 | - | 0.00(0.0%) |
Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2017 | - | 0.00(0.0%) |
Jun 2017 | - | 0.00(0.0%) |
Mar 2017 | - | 0.00(0.0%) |
Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2016 | - | 0.00(0.0%) |
Jun 2016 | - | 0.00(0.0%) |
Mar 2016 | - | 0.00(0.0%) |
Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2015 | - | 0.00(0.0%) |
Jun 2015 | - | 0.00(0.0%) |
Mar 2015 | - | 0.00(0.0%) |
Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
Sep 2014 | - | 0.00(0.0%) |
Dec 2013 | 0.00(0.0%) | 0.00 |
Dec 2012 | 0.00 | - |
FAQ
- What is BiondVax Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual debt to equity year-on-year change?
- What is BiondVax Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly debt to equity year-on-year change?
What is BiondVax Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of BVXV is -12.24
What is the all time high annual debt to equity for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual debt to equity ratio is 29.52
What is BiondVax Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, BVXV annual debt to equity ratio has changed by -41.76 (-141.46%)
What is BiondVax Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of BVXV is -3.46
What is the all time high quarterly debt to equity for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly debt to equity ratio is 29.52
What is BiondVax Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, BVXV quarterly debt to equity ratio has changed by -20.71 (-120.06%)